Jump Financial’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-76,842
Closed -$1.34M 2022
2024
Q4
$1.34M Sell
76,842
-199,688
-72% -$3.48M 0.03% 647
2024
Q3
$3.87M Buy
276,530
+239,050
+638% +$3.34M 0.08% 291
2024
Q2
$308K Sell
37,480
-33,631
-47% -$276K 0.01% 1365
2024
Q1
$548K Buy
71,111
+51,687
+266% +$399K 0.01% 1124
2023
Q4
$175K Sell
19,424
-169,501
-90% -$1.52M 0.01% 1591
2023
Q3
$1.69M Buy
188,925
+132,067
+232% +$1.18M 0.06% 439
2023
Q2
$873K Buy
+56,858
New +$873K 0.03% 752
2022
Q4
Sell
-10,757
Closed -$265K 2031
2022
Q3
$265K Sell
10,757
-49,943
-82% -$1.23M 0.01% 1211
2022
Q2
$1.47M Buy
60,700
+20,100
+50% +$487K 0.06% 436
2022
Q1
$1.05M Buy
40,600
+30,372
+297% +$782K 0.04% 508
2021
Q4
$317K Buy
+10,228
New +$317K 0.02% 864
2021
Q3
Sell
-13,200
Closed -$193K 1512
2021
Q2
$193K Buy
+13,200
New +$193K 0.02% 884